Antimicrobial activity of alcohol-free chlorhexidine mouthwashes on Candida albicans
Atividade antimicrobiana de enxaguatórios bucais sem álcool à base de clorexidina sobre Candida albicans
Maekawa, Lilian Eiko; Brighenti, Fernanda Lourenção; Lamping, Roberta; Oliveira, Luciane Dias de; Marcacci, Sidney; KOGA-ITO, Cristiane Yumi Koga-Ito
Rev. odontol. UNESP, vol.39, n1, p.15-19, 2010
Abstract
The aim of this study was to evaluate the antimicrobial activity of alcohol-free mouthwashes on Candida albicans. Twenty clinical isolates of C. albicans and one reference strain (ATCC 18804) were evaluated after exposure to two 0.12% chlorhexidine-based and alcohol-free (“Ca” and “Or”) in comparison to gluconate chlorhexidine with ethanol (positive control). The maximum inhibitory dilution (MID) and maximum fugal dilution (MFD) were determined by the microdilution method. Twelve serial dilutions (from 50 to 0.02%) were prepared in duplicate. Then, 100 μL of C. albicans suspension (106 cells.mL–1) were added to the wells. After incubation (37 °C/24 hours), MID was etermined by reading the optical density. For MFD determination, the content of the wells were plated on Saouraud agar. For MID, there were no differences between groups Or and control, but Ca group showed a MID statistically higher (Kruskal-Wallis, p = 0.0012). For MFD, there were no differences between Ca and control (Mann‑Whitney test, p = 0.1631). It can be concluded that Ca group showed a fungicid activity against C. albicans similar to the control, but lower fungistatic activity when compared to the control. Group Or showed only a fungistatic action similar to control.
Keywords
Antifungal agents, mouthwashes, Candida albicans, chlorhexidine.
Resumo
A proposta deste estudo foi avaliar a atividade antimicrobiana de enxaguatórios bucais, à base de clorexidina, sem álcool na sua composição, sobre Candida albicans. Foram avaliados vinte isolados clínicos de C. albicans e uma cepa de referência (ATCC 18804) frente a dois enxaguatórios à base de digluconato de clorexidina 0,12% e sem etanol (“Ca” e “Or”), em comparação ao enxaguatório de gluconato de clorexidina com etanol (controle positivo). A máxima diluição inibitória (MDI) e a máxima diluição fungicida (MDF) foram determinadas pelo método de microdiluição. Foram realizadas 12 diluições seriadas dos produtos (de 50 a 0,02%) em duplicata. Em seguida, foram acrescentados 100 μL da suspensão de C. albicans (106 células.mL–1) nos poços das placas. Após incubação (37 °C/24 horas), a MDI foi determinada por meio da leitura das densidades ópticas. Para determinar a MDF, foram realizadas semeaduras do conteúdo dos poços em ágar Sabouraud. Não houve diferenças estatísticas entre os grupos Or e controle para a MDI, mas o grupo Ca mostrou uma MDI estatisticamente maior (Kruskal-Wallis, p = 0,0012). Já para MDF, não houve diferenças estatísticas entre os grupos Ca e controle (Teste de Mann-Whitney, p = 0,1631). Pode-se concluir que o grupo Ca apresentou atividade fungicida sobre C. albicans semelhante ao controle, mas menor ação fungistática em comparação ao controle, enquanto que o Or apresentou apenas ação fungistática semelhante ao controle sobre os isolados avaliados.
Palavras-chave
Antimicóticos, antissépticos bucais, Candida albicans, clorexidina.
References
1. Marinho VC, Higgins JP, Logan S, Sheiham A. Fluoride mouthrinses for preventing dental caries in children and adolescents. Cochrane Database Syst Rev. 2003;(3): CD002284.
2. Bahna P, Hanna HA, Dvorak T, Vaporciyan A, Chambers M, Raad I. Antiseptic effect of a novel alcohol-free mouthwash: a convenient prophylactic alternative for high-risk patients. Oral Oncol. 2007;43:159-64.
3. Webb BC, Thomas CJ, Willcox MD, Harty DW, Knox KW. Candida-associated denture stomatitis. Aetiology and management: a review. Part 1. Factors influencing distribution of Candida species in the oral cavity. Aust Dent J. 1998;43:45–50.
4. Penha SS, Birman EG, Silveira FRX, Paula CR. Frequency and enzymatic activity (proteinase and phospholipase) of Candida albicans from edentulous patients, with and without denture stomatitis. Pesqui Odontol Bras. 2000;14:119-22.
5. Powderly WG, Robinson K, Keath EJ. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis. 1993;168:463-6.
6. Voss A, Hollis RJ, Pfaller MA, Wenzel RP, Doebbeling BN. Investigation of the sequence of colonization and candidemia in nonneutropenic patients. J Clin Microbiol. 1994;32:975-80.
7. Scully C, El-Kabir M, Samaranayake LP. Candida and oral candidosis: a review. Crit Rev Oral Biol Med. 1994;5:125-57.
8. Lortholary O, Dupont B. Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev. 1997;10:477-504.
9. Ellepola AN, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med. 2000;11:172-98.
10. Giuliana G, Pizzo G, Milici ME, Giangreco R. In vitro activities of antimicrobial agents against Candida species. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:44–9.
11. Quirynen M, Soers C, Desnyder M, Dekeyser C, Pauwels M, van Steenberghe D. A 0.05% cetylpyridinium chloride/ 0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. J Clin Periodontol. 2005;32:390–400.
12. Mankodi S, Bauroth K, Witt JJ, Bsoul S, He T, Gibb R, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent. 2005; 18 (special issue): 9A–14A.
13. van Strydonck DAC, Timmerman MF, van der Velden U, van der Weijden GA. Plaque inhibition of two commercially available chlorhexidine mouthrinses. J Clin Periodontol. 2005;32:305–9.
14. Witt J, Walters P, Bsoul S, Gibb R, Dunavent J, Putt M. Comparative clinical trial of two antigingivitis mouthrinses. Am J Dent. 2005;18(special issue): 15A–17A.
15. White DJ. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC) – The latest advance in preventive care: crest pro-health rinse. Am J Dent. 2005;18(special issue): 3A–8A.
16. Koga, CY. Quantificação da microbiota cariogênica e fúngica de anticorpos anti-Candida e anti-Streptococcus mutans na saliva de pacientes respiradores bucais. [tese doutorado]. Piracicaba: Faculdade de Odontologia da UNICAMP; 1995.
17. Sandvén P. Laboratory identification and sensitivity testing of yeast isolates. Acta Odontol Scand. 1990;48:27-36.
18. Arendorf TM, Walker DM. Denture stomatitis: a review. J Oral Rehabil. 1987;14:217-27.
19. Batista JM, Birman EG, Cury AE. Suscetibilidade a antifúngicos de cepas de Candida albicans isoladas de pacientes com estomatite protética. Rev Odontol Univ São Paulo. 1999;13:343-8.
20. Fardal O, Turnbull RS. A review of the literature on use of chlorhexidine in dentistry. J Am Dent Assoc. 1986;112:863–9.
21. Epstein JB. Antifungal therapy in oropharyngeal mycotic infections. Oral Surg Oral Med Oral Pathol. 1990;69:32–41.
22. Zegarelli DJ. Fungal infections of the oral cavity. Otolaryngol Clin North Am. 1993;26:1069–89.
23. Ferretti GA, Brown AT, Raybould TP, Lillich TT. Oral antimicrobial agents - chlorhexidine. NCI Monogr. 1990;9:51–5.
24. Arweiler NB, Netuschil L, Reich E. Alcohol-free mouthrinse solutions to reduce supragingival plaque regrowth and vitality. A controlled clinical study. J Clin Periodontol. 2001;28:168–74.
25. Quirynen M, Avontroodt P, Peeters W, Pauwels M, Coucke W, van Steenberghe D. Effect of different chlorhexidine formulations in mouthrinses on de novo plaque formation. J Clin Periodontol. 2001;28:1127-36.
26. Herrera D, Roldán S, Santacruz I, Santos S, Masdevall M, Sanz M. Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol. 2003;30:307-14.
27. Giertsen E, Bowen WH, Pearson SK. Combined effects of Zn(2+)-chlorhexidine and Zn(2+)-cetylpyridinium chloride on caries incidence in partially desalivated rats. Scand J Dent Res. 1991;99:301-9.
28. Noiri Y, Okami Y, Narimatsu M, Takahashi Y, Kawahara T, Ebisu S. Effects of chlorhexidine, minocycline, and metronidazole on Porphyromonas gingivalis strain 381 in biofilms. J Periodontol. 2003;74:1647-51.
29. Albandar JM, Gjermo P, Preus HR. Chlorhexidine use after two decades of over-the-counter availability. J Periodontol. 1994;65:109-12.
30. Budtz-Jörgensen E, Löe H. Chlorhexidine as a denture disinfectant in the treatment of denture stomatitis. Scand J Dent Res. 1972;80:457‑64.
31. Neppelenbroek KH, Campanha NH, Spolidorio DM, Spolidorio LC, Seó RS, Pavarina AC. Molecular fingerprinting methods for the discrimination between C. albicans and C. dubliniensis. Oral Dis. 2006;12:242-53.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email